Hormone replacement therapy in postmenopausal women protects against smoking-induced changes in vascular structure and function
Helena J. Teede, MBBS*,
Yu-Lu Liang, MB*,
Louise M. Shiel, BSc*,
John J. McNeil, MBBS, PhD and
Barry P. McGrath, MBBS, MD*
* Department of Medicine, Monash University, Monash Medical Centre, Clayton, Victoria, Australia
Department of Epidemiology and Preventative Medicine, Monash University, Alfred Hospital, Melbourne, Victoria, Australia

View larger version (14K):
[in a new window]
|
Figure 1 Mean (±SEM) values for intimamedia thickness (IMT, upper panel) and systemic arterial compliance (SAC, lower panel) in smokers and nonsmokers comparing those on long-term hormone replacement therapy (HRT, solid bars) vs. control subjects not on HRT (open bars). **p = 0.007, *p = 0.03.
|
|
|